Does chronic liver disease cause subclinical fat malabsorption by reducing bile acid and phospholipid secretion?

Chronic liver disease significantly impacts the biliary system's ability to process dietary fats. This impairment often occurs subclinically, meaning physiological fat absorption is compromised even when standard clinical markers, like overt steatorrhea, are absent.

Hepatic secretion and transport dysfunction

In chronic liver disease, particularly during the progression of fibrosis and cirrhosis, the liver's ability to secrete essential lipids into the bile is severely diminished.

• Transporter Downregulation: Research indicates a marked downregulation of the Bile Salt Export Pump (BSEP/ABCB11) and the Multidrug Resistance Protein 3 (MDR3/ABCB4). These canalicular transporters are responsible for exporting bile acids and phospholipids (specifically phosphatidylcholine) into the bile.
• Altered Biliary Composition: The functional impairment of these proteins leads to a contracted bile acid pool and a significant reduction in the concentration of biliary lipids. In advanced cirrhosis, while serum bile acids may rise due to portosystemic shunting, the actual biliary output—the amount of bile acid reaching the intestine—is consistently reduced.

Mechanisms of subclinical fat malabsorption

The reduction in biliary lipid secretion directly interferes with the mechanical process of fat digestion and absorption.

• Micellar Phase Disruption: Bile acids and phospholipids are required to form mixed micelles, which solubilize dietary fats for intestinal uptake. When secretion levels drop, the formation of this micellar phase is impaired, reducing the efficiency of fat transport across the intestinal lumen.
• The Steatorrhea Threshold: Overt steatorrhea is typically defined as fecal fat excretion exceeding 7g/day. However, sensitive diagnostic tools like the $^{13}$C-triolein breath test reveal that many patients with chronic liver disease suffer from fat malabsorption that falls below this threshold. This subclinical malabsorption can lead to micronutrient deficiencies (especially fat-soluble vitamins A, D, E, and K) without the classic symptoms of fatty, voluminous stools.

Bottom line

Chronic liver disease reduces bile acid and phospholipid secretion through the downregulation of canalicular transporters. This leads to impaired micelle formation and significant fat malabsorption, which frequently occurs at a subclinical level without manifesting as overt steatorrhea.